SEC 13F Intelligence

Verdad Advisers, LP / CLYM

Verdad Advisers, LP’s Climb Bio Inc Position

Does Verdad Advisers, LP own Climb Bio Inc (CLYM)? Yes144.5K shares worth $990,099 (+1.11% of its 13F portfolio) as of Q1 2026.

Position Value
$990,099
Q1 2026
Shares
144.5K
% of Portfolio
+1.11%
Quarters Held
1
currently held

Position History CLYM

Reported value by quarter
Q1 ’26: $990,099Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026144.5K$990,099+1.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Verdad Advisers, LP’s full portfolio or all institutional holders of CLYM.